When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-Through

Abstract excerpt

Drug shortages represent persistent supply disruptions in the U.S. pharmaceutical market, threatening patient access and increasing drug costs. Prior research commonly treats shortages as binary events and relies on static designs, limiting insight into how shortage characteristics drive cost escalation. This study uncovers the heterogeneity behind drug shortages and pharmacy acquisition costs of generic non-injec...

Topics

Open a Topic to create a Post that cites this publication.

• Carcinoma, Non-Small-Cell Lung
• China
• Gefitinib
• Health Systems, Economic Evaluations, Quality of Life
• Lung Neoplasms
• Lysosomal Storage Disorders Research
• Mutation

Identifiers and source

Literature Corpus work

a581582d-c957-5e98-9617-4411eee85328

DOI

10.64898/2026.07.27.26359030